Vienna, Austria

Hubert Pehamberger

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Hubert Pehamberger

Introduction

Hubert Pehamberger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the study of human endogenous retroviruses. With a total of 3 patents, his work has implications for understanding infectious diseases and developing potential therapeutic approaches.

Latest Patents

Pehamberger's latest patents focus on polynucleotide fragments of an infectious human endogenous retrovirus. One of his key inventions involves nucleotide sequences and fragments that code for a human endogenous retrovirus, which is infectious. These fragments are related to specific sequences inserted into the vector pCR4-Topo and deposited as MERV-env, MERV-gag, MERV-prt, and MERV-pol. Additionally, his patents describe methods of using these sequences, polypeptides encoded by them, antibodies directed against these sequences, and related methods and compositions.

Career Highlights

Throughout his career, Hubert Pehamberger has worked with various organizations, including Avir Green Hills Biotechnology Research Development Trade AG. His research has contributed to advancements in the understanding of retroviruses and their potential impact on human health.

Collaborations

Pehamberger has collaborated with notable colleagues in his field, including Klaus Wolff and Andreas Grassauer. These partnerships have enhanced his research and expanded the reach of his innovations.

Conclusion

Hubert Pehamberger's work in the field of biotechnology, particularly regarding human endogenous retroviruses, showcases his innovative spirit and dedication to advancing scientific knowledge. His patents and collaborations reflect a commitment to addressing complex health challenges through research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…